Page last updated: 2024-10-22

aminoglutethimide and Klinefelter Syndrome

aminoglutethimide has been researched along with Klinefelter Syndrome in 1 studies

Aminoglutethimide: An aromatase inhibitor that is used in the treatment of advanced BREAST CANCER.
aminoglutethimide : A dicarboximide that is a six-membered cyclic compound having ethyl and 4-aminophenyl substituents at the 3-position.

Klinefelter Syndrome: A form of male HYPOGONADISM, characterized by the presence of an extra X CHROMOSOME, small TESTES, seminiferous tubule dysgenesis, elevated levels of GONADOTROPINS, low serum TESTOSTERONE, underdeveloped secondary sex characteristics, and male infertility (INFERTILITY, MALE). Patients tend to have long legs and a slim, tall stature. GYNECOMASTIA is present in many of the patients. The classic form has the karyotype 47,XXY. Several karyotype variants include 48,XXYY; 48,XXXY; 49,XXXXY, and mosaic patterns ( 46,XY/47,XXY; 47,XXY/48,XXXY, etc.).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brown, PW1
Terz, JJ1

Other Studies

1 other study available for aminoglutethimide and Klinefelter Syndrome

ArticleYear
Breast carcinoma associated with Klinefelter syndrome: a case report.
    Journal of surgical oncology, 1978, Volume: 10, Issue:5

    Topics: Adrenal Glands; Adult; Aminoglutethimide; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating;

1978